Apsen Farmaceutica S.a.
Clinical trials sponsored by Apsen Farmaceutica S.a., explained in plain language.
-
New hair loss drug enters final testing phase
Disease control Not yet recruitingThis study tests a new medicine called APSMNF for male pattern baldness. About 336 men aged 18 to 60 will receive either the treatment or a placebo. The main goal is to see if it increases hair density and is safe to use.
Phase: PHASE3 • Sponsor: Apsen Farmaceutica S.A. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New sleep aid APSTZD put to the test in Mid-Stage trial
Symptom relief Not yet recruitingThis study tests a new insomnia drug, APSTZD, to see if it helps people stay asleep. About 222 adults with chronic insomnia will receive either APSTZD, an active comparator, or a placebo for 6 weeks. The main goal is to measure how much time they spend awake after falling asleep,…
Phase: PHASE2 • Sponsor: Apsen Farmaceutica S.A. • Aim: Symptom relief
Last updated May 01, 2026 15:57 UTC